Search

Your search keyword '"Michel, Marc"' showing total 1,522 results

Search Constraints

Start Over You searched for: Author "Michel, Marc" Remove constraint Author: "Michel, Marc"
1,522 results on '"Michel, Marc"'

Search Results

3. Listeria monocytogenes-associated spontaneous bacterial peritonitis in France: a nationwide observational study of 208 cases

5. Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials

7. Severe adult hemophagocytic lymphohistiocytosis (HLHa) correlates with HLH-related gene variants

8. Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial

9. SARS-CoV-2 Omicron BA.1 breakthrough infection drives late remodeling of the memory B cell repertoire in vaccinated individuals

10. Microsatellite instability detection in breast cancer using drop-off droplet digital PCR

11. Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study

12. Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study

13. Immune thrombocytopenia and pregnancy: an exposed/nonexposed cohort study

14. Listeria monocytogenes-associated spontaneous bacterial peritonitis in France: a nationwide observational study of 208 cases

15. Characterisation of a high-risk profile for maternal thrombotic and severe haemorrhagic complications in pregnant women with antiphospholipid syndrome in France (GR2): a multicentre, prospective, observational study

17. Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial

18. Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study group

21. Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial

22. SrTiO3 thin film photoanodes fabricated by combinatorial chemical beam vapour deposition: intricate connection between elemental composition and thin films' properties.

24. DPP4 inhibition impairs senohemostasis to improve plaque stability in atherosclerotic mice

25. Evans syndrome in adults: an observational multicenter study

26. Non-invasive multi-cancer diagnosis using DNA hypomethylation of LINE-1 retrotransposons

27. Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen : observational comparative study using routine care data

29. Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

31. Clinical presentation, course, and prognosis of patients with mixed connective tissue disease: A multicenter retrospective cohort.

32. Difficult‐to‐treat primary immune thrombocytopenia in adults: Prevalence and burden. Results from the CARMEN‐France registry.

34. Clinical presentation, course, and prognosis of patients with mixed connective tissue disease: A multicenter retrospective cohort

36. Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial

38. Updated international consensus report on the investigation and management of primary immune thrombocytopenia

40. Characterization of Chromium Bioremediation Products in Flow-Through Column Sediments Using Micro-X-ray Fluorescence and X-ray Absorption Spectroscopy.

42. Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study

43. High-affinity autoreactive plasma cells disseminate through multiple organs in patients with immune thrombocytopenic purpura

44. Platelet count threshold for hemorrhage in patients with immune thrombocytopenia treated with antiplatelet agents

45. Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial

46. Severe adult hemophagocytic lymphohistiocytosis (HLHa) correlates with HLH-related gene variants

47. 26 Sustained complement C1s inhibition with sutimlimab in patients with cold agglutinin disease results in continued efficacy during part B of the randomized placebo-controlled phase 3 CADENZA study (NCT03347422)

48. Single-cell and spatial transcriptomics uncovers the role of senescent vascular cells in pathological arterial remodeling during atherosclerosis

49. P1471: SUSTAINED EFFICACY OF SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IN PATIENTS WITH COLD AGGLUTININ DISEASE: RESULTS FROM PART B OF THE PHASE 3 CADENZA STUDY

50. PB2625: VAYHIT2: A RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL OF IANALUMAB VS PLACEBO IN ADDITION TO ELTROMBOPAG IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) WHO FAILED FIRST-LINE STEROID TREATMENT

Catalog

Books, media, physical & digital resources